Back to search
Phase I-II study of eflornithine and mitoguazone combined in the treatment of recurrent primary brain tumors.
Data up to Jan 2025
Published1987
Citations39
References0
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
Loading...